WebCisplatin is one of the most broadly used chemotherapeutic agents. Several central nervous system toxicities have been attributed to this agent, among which is a rare clinicoradiological condition referred to as posterior reversible leukoen-cephalopathy syndrome (PRES) or reversible posterior leukoencephalopathy syndrome (RPLS). WebJun 23, 2024 · I'm often giving Cisplatin to patients 65+ for bladder, head/neck cancer, or esophageal cancer. Many have hypertension as a comorbidity. We have been additionally hydrating the patients twice weekly with 1L of fluid at least, with some patients getting up to an additional liter or two if needed.
Cisplatin-Induced Posterior Reversible Encephalopathy Syndrome—Brief ...
WebAug 26, 2016 · Conclusions: Cisplatin is a documented causative agent of PRES though gemcitabine is rarely associated with the syndrome. Combination cisplatin and gemcitabine therapy causing radiologically proven PRES has been documented in only 3 … WebApr 10, 2024 · Systemic therapy is considered standard of care for previously untreated BTC and often includes gemcitabine and cisplatin chemotherapy as established by the phase III ABC-02 trial ... Many had hypertension (308, 60.5%), while 187 had CVD (36.7%), 120 had diabetes (23.6%), 131 had dyslipidemia (25.7%), and 65 had CKD (12.8%). Gender, … how did mary pickford impact the 1920s
Cisplatin Pre & Post Hydration - Oncology Nursing - allnurses
WebJan 7, 2024 · Data on the following variables were recorded: age, sex, diagnosis, height, weight, mannitol treatment, cisplatin treatment (number of treatments and absolute dose), hypertension (current antihypertensive treatment), diabetes, use of acetylsalicylic acid, use of angiotensin-converting enzyme (ACE)-inhibitors, tobacco use, exposure to ... WebFeb 20, 2024 · Cisplatin is a platinum-based anticancer drug widely used to treat various types of cancer and contributes to the improvement in outcomes like 5-year survival. However, side effects of cisplatin including ototoxicity, neurotoxicity, nausea, and myelosuppression frequently occur, and the main dose-limiting side effect is … http://www.ajnr.org/content/ajnr/19/3/415.full.pdf how many sides do a parallelogram have